Chiesi Global Rare Diseases is seeking research proposals for new technologies from academic medical centres, universities, and research institutions globally. Their objective is to award funds to validate early‑stage projects with clear therapeutic potential. Successful applicants will be funded through sponsored research, with up to $275K/€250K available per project for 2 years duration.
This should enable researchers to generate relevant preclinical data or demonstrate preclinical proof of concept for technologies enabling effective biodistribution of macromolecules (for example: nucleic acids, proteins) to the following tissues of interest, characterised by challenges in delivery (any or all):
for the treatment of rare metabolic disorders, for example inborn errors of metabolism, including lysosomal storage disorders. The technology might be brought into the Chiesi Global Rare Diseases pipeline and ultimately benefit patients.
What Chiesi Is Looking For
Chiesi Global Rare Diseases is seeking new technologies with key attributes including some of the following:
Therapeutic Area of Interest for 2022
Delivery technologies that can be applied to the treatment of rare metabolic disorders, for example inborn errors of metabolism, including lysosomal storage disorders.
Submission Information
The first step in the process is submission of a Pre‑Proposal which should contain a brief, non‑confidential 2‑3 page overview of the target, mechanism (including evidence for link to disease), and the proposed therapeutic opportunity. To submit your proposal, please visit our website at discover.in-part.com, register, and submit your research pre‑proposal under the appropriate Discover campaign. A more detailed Full Proposal will be solicited by invitation only.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.